The Process Development Blog

[WEBINAR] Scale-up of crystallization processes is rarely trivial & often necessitates careful consideration and in-depth understanding of process parameters.

[WEBINAR] Delve into APC’s Continuous Manufacturing philosophy, especially the use of continuous crystallization, modeling, design and PAT applications.

APC unveils €25m investment and 120 jobs to accelerate development and manufacture of Covid Vaccines and Advanced Therapeutics.

Our expert, Dr. Jacek Zeglinski talks about the various challenges which drug substance developers face when seeking to develop material suitable for tabletting

Particle sizing is hugely important. However, it is laden with complexities and there is a general misunderstanding of the techniques used.

[WEBINAR] Industry bottlenecks in drug substance development: solubility, particle size, and morphology.

Industry Veteran Brett Huff has joined APC to head up our First-in-Class Digital Strategy for process development.

Subtle changes in particle size, shape, & distribution can have a major impact on pharma solubility and stability and cause flow and formulation issues.

At APC, we’re very proud of the fact that we help companies accelerate the development of therapeutics for rare diseases.

[WEBINAR] Good crystallization process design, can save months of development time. But, crystallization of stereoisomers can be particularly challenging.